Cargando…
Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor
The gut microbiota is essential for human health. Microbial supply of short-chain fatty acids (SCFAs), particularly butyrate, is a well-established contributor to gut homeostasis and disease resistance. Reaching millimolar luminal concentrations, butyrate is sequestered and utilized in the colon as...
Autores principales: | Wang, Ruth X., Henen, Morkos A., Lee, J. Scott, Vögeli, Beat, Colgan, Sean P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253137/ https://www.ncbi.nlm.nih.gov/pubmed/34190032 http://dx.doi.org/10.1080/19490976.2021.1938380 |
Ejemplares similares
-
The role of HIF prolyl hydroxylases in tumour growth
por: Jokilehto, Terhi, et al.
Publicado: (2010) -
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
por: Yeh, Tzu-Lan, et al.
Publicado: (2017) -
HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
por: Poloznikov, Andrey A., et al.
Publicado: (2021) -
Activity and Affinity of Pin1 Variants
por: Born, Alexandra, et al.
Publicado: (2019) -
HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
por: Hirota, Kiichi
Publicado: (2021)